Yellow Fever Vaccine: The Conundrum of 2 Doses, One Dose, or One-Fifth Dose to Induce and Maintain Protective Immunity.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Immune response to co-administration of measles, mumps, and rubella (MMR), and yellow fever vaccines: a randomized non-inferiority trial among one-year-old children in Argentina.BMC infectious diseases · 2023
   Trial
2. Immunological and transcriptomic profile of chimeric live-attenuated Zika vaccine linked to protection in non-human primates.Nature communications · 2025
   Article
3. Safety and Immunogenicity of the Attenuated Yellow Fever Vaccine in Several Neotropical Primate Species.Vaccines · 2025
   Article
4. Fractional Dosing of Yellow Fever Live Attenuated 17D Vaccine: A Perspective.Infection and drug resistance · 2023
   Article
5. A High-Throughput Yellow Fever Neutralization Assay.Microbiology spectrum · 2022
   Article
6. The global burden of yellow fever.eLife · 2021
   Article
7. Re-emergence of yellow fever in the neotropics - quo vadis?Emerging topics in life sciences · 2020
   Review
8. Anti-Flavivirus Vaccines: Review of the Present Situation and Perspectives of Subunit Vaccines Produced inVaccines · 2020
   Review
9. Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection.NPJ vaccines · 2020
   Review

Corrections and comments

• Comment on
  Persistence of Neutralizing Antibody Responses Among Yellow Fever Virus 17D Vaccinees Living in a Nonendemic Setting.2020
• Comment on
  Global Risk and Elimination of Yellow Fever Epidemics.2020

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as